156 related articles for article (PubMed ID: 19058140)
1. Inhibition of AR-mediated transcription by binding of Oct1 to a motif enriched in AR-occupied regions.
Jariwala U; Cogan JP; Jia L; Frenkel B; Coetzee GA
Prostate; 2009 Mar; 69(4):392-400. PubMed ID: 19058140
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel androgen receptor target genes in prostate cancer.
Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
[TBL] [Abstract][Full Text] [Related]
3. Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity.
Jia L; Berman BP; Jariwala U; Yan X; Cogan JP; Walters A; Chen T; Buchanan G; Frenkel B; Coetzee GA
PLoS One; 2008; 3(11):e3645. PubMed ID: 18997859
[TBL] [Abstract][Full Text] [Related]
4. Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth.
Obinata D; Takayama K; Fujiwara K; Suzuki T; Tsutsumi S; Fukuda N; Nagase H; Fujimura T; Urano T; Homma Y; Aburatani H; Takahashi S; Inoue S
Oncogene; 2016 Dec; 35(49):6350-6358. PubMed ID: 27270436
[TBL] [Abstract][Full Text] [Related]
5. Oct1 regulates cell growth of LNCaP cells and is a prognostic factor for prostate cancer.
Obinata D; Takayama K; Urano T; Murata T; Kumagai J; Fujimura T; Ikeda K; Horie-Inoue K; Homma Y; Ouchi Y; Takahashi S; Inoue S
Int J Cancer; 2012 Mar; 130(5):1021-8. PubMed ID: 21387309
[TBL] [Abstract][Full Text] [Related]
6. Integrative Genomic Analysis of OCT1 Reveals Coordinated Regulation of Androgen Receptor in Advanced Prostate Cancer.
Takayama KI; Suzuki Y; Yamamoto S; Obinata D; Takahashi S; Inoue S
Endocrinology; 2019 Feb; 160(2):463-472. PubMed ID: 30649323
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor.
Obinata D; Takayama K; Lawrence MG; Funakoshi D; Hara M; Niranjan B; Teng L; Taylor RA; Risbridger GP; Takahashi S; Inoue S
BMC Cancer; 2024 May; 24(1):554. PubMed ID: 38698344
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor-mediated repression of novel target genes.
Prescott J; Jariwala U; Jia L; Cogan JP; Barski A; Pregizer S; Shen HC; Arasheben A; Neilson JJ; Frenkel B; Coetzee GA
Prostate; 2007 Sep; 67(13):1371-83. PubMed ID: 17624924
[TBL] [Abstract][Full Text] [Related]
9. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model.
Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA
Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277
[TBL] [Abstract][Full Text] [Related]
10. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
Yuan H; Gong A; Young CY
Carcinogenesis; 2005 Apr; 26(4):793-801. PubMed ID: 15661808
[TBL] [Abstract][Full Text] [Related]
11. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
Dai JL; Burnstein KL
Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268
[TBL] [Abstract][Full Text] [Related]
12. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
Thomas MA; Preece DM; Bentel JM
Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863
[TBL] [Abstract][Full Text] [Related]
13. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells.
Ikezoe T; Chen SS; Yang Y; Heber D; Taguchi H; Koeffler HP
Int J Oncol; 2003 Nov; 23(5):1461-70. PubMed ID: 14532991
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
15. OCT1-target neural gene PFN2 promotes tumor growth in androgen receptor-negative prostate cancer.
Obinata D; Funakoshi D; Takayama K; Hara M; Niranjan B; Teng L; Lawrence MG; Taylor RA; Risbridger GP; Suzuki Y; Takahashi S; Inoue S
Sci Rep; 2022 Apr; 12(1):6094. PubMed ID: 35413990
[TBL] [Abstract][Full Text] [Related]
16. Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.
Li N; Chen M; Truong S; Yan C; Buttyan R
Prostate; 2014 Oct; 74(14):1400-10. PubMed ID: 25132524
[TBL] [Abstract][Full Text] [Related]
17. Identification of new octamer transcription factor 1-target genes upregulated in castration-resistant prostate cancer.
Yamamoto S; Takayama KI; Obinata D; Fujiwara K; Ashikari D; Takahashi S; Inoue S
Cancer Sci; 2019 Nov; 110(11):3476-3485. PubMed ID: 31454442
[TBL] [Abstract][Full Text] [Related]
18. Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells.
Emami KH; Brown LG; Pitts TE; Sun X; Vessella RL; Corey E
Prostate; 2009 Oct; 69(14):1481-92. PubMed ID: 19514049
[TBL] [Abstract][Full Text] [Related]
19. The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor.
Rajan P; Gaughan L; Dalgliesh C; El-Sherif A; Robson CN; Leung HY; Elliott DJ
J Pathol; 2008 May; 215(1):67-77. PubMed ID: 18273831
[TBL] [Abstract][Full Text] [Related]
20. CA916798 affects growth and metastasis of androgen-dependent prostate cancer cells.
He J; Lan X; Duan HL; Luo H; Zhou XD
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4477-4487. PubMed ID: 30058677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
